Sign in

CIK 0000073290

  • Non-accelerated filer
  • Smaller reporting company

BIOMERICA INC

Sign in to watch
Ticker
BMRA
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
May 31
Incorporated
DE
Entity type
Operating
EIN
952645573
Phone
+1 949-379-2875
Business address
17571 VON KARMAN AVENUE, IRVINE, CA, 92614
  1. 4 Gift Chief Financial Officer gave 16,000 shares (gift)
  2. 4 Other acquisition Chief Executive Officer acquired 3,600 shares (other)
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Other acquisition Chief Executive Officer acquired 1,200 shares (other)
  10. 4 Other acquisition Chief Executive Officer acquired 33,390 shares (other)
  11. 4 Exercise or conversion Director acquired 25,000 shares (option exercise)
  12. 4 Exercise or conversion Director acquired 25,000 shares (option exercise)
  13. 4 Exercise or conversion Director acquired 25,000 shares (option exercise)
  14. 4 Other acquisition Director acquired 6,700 shares (other)
  15. 4 Other acquisition Director acquired 9,400 shares (other)
  16. 4 Other acquisition Director acquired 8,000 shares (other)
  17. 4 Other acquisition Chief Executive Officer acquired 25,000 shares (other)
  18. 4 Open-market buy Chief Executive Officer bought 500 shares at $3.83 ($1,915)
  19. 4 Open-market buy Chief Executive Officer bought 1,000 shares at $3.96 ($3,960)
  20. 4 Open-market buy Chief Executive Officer bought 2,539 shares at an average $3.99 ($10,134)

Page 5 of 12 · 236 filings